Clinical Trials Directory

Trials / Unknown

UnknownNCT01719211

Genetic Basis of Mitral Valve Prolapse

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators have successfully identified two novel genetic loci for MVP on chromosomes 11 and 13 and are searching for altered genes in these regions. This requires recruiting large families who may have MVP linked to these or other chromosomes; and obtaining DNA samples from 1,000-1,500 individually affected patients to study the relation between DNA markers throughout the genome and MVP. It is our expectation that the results of this study will lead to the discovery of gene(s) responsible for MVP. This will lead to improved understanding of the disease and, in turn, improved ability to treat and prevent progression in genetically susceptible individuals.

Detailed description

This is a genome-wide association study.

Conditions

Timeline

Start date
1999-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2012-11-01
Last updated
2023-11-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01719211. Inclusion in this directory is not an endorsement.